Estetrol/Drospirenone to Reduce the Average Size of Endometriomas
Estetrol/Drospirenone to Reduce the Average Size of Endometriomas
Recruiting · NCT05837624 · Registry updated 2025-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Estetrol/Drospirenone to Reduce the Average Size of Endometriomas | Endometrioma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Urogenital Diseases, endometriosis, female reproductive system disorder | Recruiting | Phase 4 | 2025-04-06 | NCT05837624 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Andrew Zakhari | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| McGill University Health Center | Montreal | Canada | 27 |